Sign up
Quantellect · Congress · Trade Detail
NYSE: ABTAbbott Laboratories
RepublicanHouse

Dave Camp sold Abbott Laboratories (NYSE: ABT)

Dave Camp (R-MI), a U.S. Representative, has disclosed 10 trades in Abbott Laboratories (ABT) since 2014, 5 purchases and 5 sales, worth an estimated $80K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Dave Camp sold $1,000 - $15,000 of Abbott Laboratories (NYSE: ABT) on May 16, 2014. Since that trade, ABT is up +248.46% against the S&P 500 up +375.47%, an outperformance of -127.01%.

Across these filings, Dave Camp has been a balanced trader of ABT (a buy-to-sell ratio of 1.00). The most recent disclosed ABT transaction shown was dated September 26, 2014. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ABT trades
10
Disclosed Vol
$80K
Buys
5
50%
Sells
5
50%
Buy / Sell
1.00
ratio
First → Last
2014

Dave Camp's ABT trades vs the price

ABT is up +248.46% since Dave Camp sold on May 16, 2014, versus +375.47% for the S&P 500.

Performance since this trade

Price change since trade
+248.46%
S&P 500 change since trade
+375.47%
Outperformance vs S&P 500
-127.01%

All Dave Camp ABT trades

TradedTypeSizeReturnEst. profit
September 26, 2014SELL$33.51+222.26%
May 16, 2014BUY$30.99+248.46%+$14K
May 16, 2014SELL$30.99+248.46%
May 16, 2014SELL$30.99+248.46%
May 16, 2014BUY$30.99+248.46%+$14K
May 16, 2014BUY$30.99+248.46%+$14K
May 16, 2014BUY$30.99+248.46%+$14K
May 16, 2014SELL$30.99+248.46%
May 16, 2014BUY$30.99+248.46%+$14K
May 16, 2014SELL$30.99+248.46%

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Dave Camp & ABT trading FAQ

Is it legal for Dave Camp to trade Abbott Laboratories (ABT) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Abbott Laboratories (ABT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Dave Camp sell ABT?

Dave Camp disclosed a sale of $1,000 - $15,000 of Abbott Laboratories (ABT) on May 16, 2014, according to public STOCK Act filings.

How has ABT performed since Dave Camp's trade?

Since Dave Camp sold ABT on May 16, 2014, the stock is up +248.46%, versus +375.47% for the S&P 500 over the same period, an outperformance of -127.01%.

How many times has Dave Camp traded ABT?

Dave Camp has disclosed 10 ABT trades since 2014 (5 purchases and 5 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ABT trades?

Quantellect tracks every disclosed congressional trade in Abbott Laboratories (ABT) on the Abbott Laboratories congressional trading page, which aggregates filings across all members of Congress.

Dave Camp's ABT tradesAll congressional filings for Abbott LaboratoriesDave Camp's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.